Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F van de Werf

Showing results (41-50 of 290) with videos related to

Pageof 29
Sort By:
Lancet (London, England)|December 16, 2000
Intracranial haemorrhage with bolus thrombolytic agentsP W Armstrong, C Granger, F Van de Werf
Circulation|February 27, 2001
Bolus fibrinolysis: risk, benefit, and opportunitiesP W Armstrong, C Granger, F Van de Werf
Acta Cardiologica|October 21, 2000
Failure of medicine: evolution of an atrial septal defect to an Eisenmenger syndromeW Budts, J Van Cleemput, F Van de Werf
Coronary Artery Disease|October 1, 1993
Coronary thrombolysis with K1K2Pu, a chimeric tissue-type and urokinase-type plasminogen activator: a feasibility study in six patients with acute myocardial infarctionF Van de Werf, H R Lijnen, D Collen
Journal of Cardiovascular Pharmacology|January 1, 1987
Thrombolysis with recombinant human single-chain urokinase-type plasminogen activator (rscu-PA): dose-response in dogs with coronary artery thrombosisF Van de Werf, I K Jang, D Collen
Acta Cardiologica|January 1, 1992
Thrombolytic therapy and acute aortic dissectionD Mertens, M C Herregods, F van de Werf
American Heart Journal|November 1, 1986
Coronary thrombolysis in patients with acute myocardial infarction by intravenous infusion of synergic thrombolytic agentsD Collen, D C Stump, F Van de Werf
Pflugers Archiv : European Journal of Physiology|February 1, 1987
Geometrical variations of the canine superior vena cava: relationship between diameter, segment length and transmural venous pressureJ Minten, F Van de Werf, H De Geest
Journal of Thrombosis and Haemostasis : JTH|January 11, 2014
Dabigatran versus warfarin in patients with mechanical heart valves: replyJ W Eikelboom, M Brueckmann, F van de Werf
Circulation Research|December 24, 1997
Low efficiency of Ca2+ entry through the Na(+)-Ca2+ exchanger as trigger for Ca2+ release from the sarcoplasmic reticulum. A comparison between L-type Ca2+ current and reverse-mode Na(+)-Ca2+ exchangeK R Sipido, M Maes, F Van de Werf
Pageof 29

Showing results (41-50 of 290) with videos related to

Sort By:
Pageof 29
Lancet (London, England)|December 16, 2000
Intracranial haemorrhage with bolus thrombolytic agentsP W Armstrong, C Granger, F Van de Werf
Circulation|February 27, 2001
Bolus fibrinolysis: risk, benefit, and opportunitiesP W Armstrong, C Granger, F Van de Werf
Acta Cardiologica|October 21, 2000
Failure of medicine: evolution of an atrial septal defect to an Eisenmenger syndromeW Budts, J Van Cleemput, F Van de Werf
Coronary Artery Disease|October 1, 1993
Coronary thrombolysis with K1K2Pu, a chimeric tissue-type and urokinase-type plasminogen activator: a feasibility study in six patients with acute myocardial infarctionF Van de Werf, H R Lijnen, D Collen
Journal of Cardiovascular Pharmacology|January 1, 1987
Thrombolysis with recombinant human single-chain urokinase-type plasminogen activator (rscu-PA): dose-response in dogs with coronary artery thrombosisF Van de Werf, I K Jang, D Collen
Acta Cardiologica|January 1, 1992
Thrombolytic therapy and acute aortic dissectionD Mertens, M C Herregods, F van de Werf
American Heart Journal|November 1, 1986
Coronary thrombolysis in patients with acute myocardial infarction by intravenous infusion of synergic thrombolytic agentsD Collen, D C Stump, F Van de Werf
Pflugers Archiv : European Journal of Physiology|February 1, 1987
Geometrical variations of the canine superior vena cava: relationship between diameter, segment length and transmural venous pressureJ Minten, F Van de Werf, H De Geest
Journal of Thrombosis and Haemostasis : JTH|January 11, 2014
Dabigatran versus warfarin in patients with mechanical heart valves: replyJ W Eikelboom, M Brueckmann, F van de Werf
Circulation Research|December 24, 1997
Low efficiency of Ca2+ entry through the Na(+)-Ca2+ exchanger as trigger for Ca2+ release from the sarcoplasmic reticulum. A comparison between L-type Ca2+ current and reverse-mode Na(+)-Ca2+ exchangeK R Sipido, M Maes, F Van de Werf
Pageof 29